TCMD Share Price Performance
US$28.72
13.67 (90.83%)
3.5% undervalued intrinsic discount
US$29.75
Fair Value
Price US$28.72
AnalystConsensusTarget US$29.75
AnalystLowTarget US$16.00
AnalystHighTarget US$32.00
Fair ValueUS$29.75
Share Pricen/a
Tactile Systems Technology, Inc. Stock Price
- 3 Narratives written by author
- 0 Comments on narratives written by author
- 24 Fair Values set on narratives written by author
TCMD Community Narratives
AN
Fair Value US$29.75 3.5% undervalued intrinsic discount
TCMD: Market Leadership And Coverage Momentum Will Drive Expansion Into Underserved Patients
0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
AN
Fair Value US$16 79.5% overvalued intrinsic discount
AI Execution And Policy Dependence Will Pressure Margins And Limit Earnings Upside
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
Fair Value US$32 10.3% undervalued intrinsic discount
Lymphedema Tailwinds And AI Workflow Efficiencies Will Drive Significant Long Term Upside
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
TCMD: Market Leadership And Coverage Momentum Will Drive Expansion Into Underserved Patients
Key Takeaways Expanding product portfolio and investment in technology are enhancing market reach, salesforce productivity, and operational efficiency, supporting steadier long-term growth. Shifts toward at-home care and improved reimbursement are increasing demand, broadening patient access, and strengthening revenue stability beyond traditional core products.Read more
111
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
11users have followed this narrative
AN
US$29.75
3.5% undervalued intrinsic discount
AnalystConsensusTarget's Fair Value
Revenue
8.96% p.a.
Profit Margin
7.95%
Future PE
20.88x
Price in 2029
US$33.77
AI Execution And Policy Dependence Will Pressure Margins And Limit Earnings Upside
Catalysts About Tactile Systems Technology Tactile Systems Technology develops and sells medical devices for lymphedema and airway clearance, including home-use compression and vest systems. What are the underlying business or industry changes driving this perspective?Read more
12
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$16
79.5% overvalued intrinsic discount
AnalystLowTarget's Fair Value
Revenue
9.09% p.a.
Profit Margin
7.44%
Future PE
12.62x
Price in 2029
US$19.16
Lymphedema Tailwinds And AI Workflow Efficiencies Will Drive Significant Long Term Upside
Catalysts About Tactile Systems Technology Tactile Systems Technology develops and commercializes medical devices that treat chronic lymphedema and airway clearance conditions, focusing on home-based, clinically validated therapies. What are the underlying business or industry changes driving this perspective?Read more
11
users have viewed this narrative0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
US$32
10.3% undervalued intrinsic discount
AnalystHighTarget's Fair Value
Revenue
10.03% p.a.
Profit Margin
9.36%
Future PE
19.54x
Price in 2028
US$40.01
Trending Discussion
Recently Updated Narratives
AN
TCMD: Index Inclusion And Stable Outlook Will Shape Measured Turnaround Expectations
Fair Value: US$29.75 3.5% undervalued intrinsic discount
11 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AI Execution And Policy Dependence Will Pressure Margins And Limit Earnings Upside
Fair Value: US$16 79.5% overvalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
Lymphedema Tailwinds And AI Workflow Efficiencies Will Drive Significant Long Term Upside
Fair Value: US$32 10.3% undervalued intrinsic discount
0 followersusers have followed this narrative
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
Snowflake Analysis
Tactile Systems Technology, Inc. Key Details
About TCMD
- Founded
- 1995
- Employees
- 1086
- CEO
- WebsiteView website
Tactile Systems Technology, Inc., a medical technology company, develops and provides medical devices to treat underserved chronic diseases in the United States. It offers Flexitouch Plus system, a pneumatic compression device for the treatment of lymphedema, phlebolymphedema, lipedema, venous insufficiencies, and other types of edema and leg ulcers; Entre Plus System, a pneumatic compression device for the at-home treatment of lymphedema, chronic edema, venous insufficiency, and chronic wounds. The company also provides Nimbl, a pneumatic compression platform for the treatment of upper extremity lymphedema; Kylee, a mobile application to help patients learn about lymphedema, track their symptoms, and treatment, as well as to share their progress with their doctor; and AffloVest, a portable high frequency chest wall oscillation vest to treat patients with retained pulmonary secretions resulting from bronchiectasis, cystic fibrosis, and various neuromuscular disorders. Tactile Systems Technology, Inc. was incorporated in 1995 and is headquartered in Minneapolis, Minnesota.
